Artelo Biosciences Inc (ARTL)

Artelo Biosciences Inc Aktie (ARTL) Neueste Nachrichten

Artelo Biosciences' (ARTL) “Buy” Rating Reiterated at HC Wainwright - Defense World

Defense World

Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update - Investing.com South Africa

Investing.com South Africa

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th

GlobeNewswire Inc.

Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14th - Investing.com South Africa

Investing.com South Africa

Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapy

GlobeNewswire Inc.

Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Time

GlobeNewswire Inc.

Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Update - Yahoo Finance

Yahoo Finance

Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation Challenge

GlobeNewswire Inc.

Artelo named finalist in J&J innovation challenge By Investing.com - Investing.com

Investing.com

Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral Neuropathy

GlobeNewswire Inc.

Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12

GlobeNewswire Inc.

Artelo Biosciences Inc. (NASDAQ: ARTL) Announce Fiscal Year 2021 Results And Updates On ART27.13 Study - BP Journal

BP Journal

Artelo Biosciences (ARTL): Drug Cannibalization By Cannabis Will Dwindle Potential Revenue - Seeking Alpha

Seeking Alpha

Artelo Biosciences Reports First Quarter Fiscal Year 2021 Financial Results and Provides Business Update - Yahoo Finance

Yahoo Finance

Artelo Biosciences (NASDAQ:ARTL) Files Patents For FATTY ACID Binding Protein 5 Inhibitors Use In Psychological ... - BP Journal

BP Journal

Artelo Biosciences Inc (NASDAQ:ARTL) Posts Net Loss Of $951395 In Q3 2020 - BP Journal

BP Journal

Here's Why We're A Bit Worried About Artelo Biosciences's (NASDAQ:ARTL) Cash Burn Situation - Yahoo Finance

Yahoo Finance

Artelo Biosciences Announces Selection of Aptus Clinical Ltd. as Clinical Research Organization for Phase 1b/2a ... - GlobeNewswire

GlobeNewswire

Artelo Biosciences Announces Pricing of $8.0 Million Public Offering and Uplisting to Nasdaq - GlobeNewswire

GlobeNewswire

New Drugs Using the Body's Natural “Marijuana” Could Help Treat Pain, Cancer - SBU News - Stony Brook News

Stony Brook News